1.1.   Report Description

1.2.   Research Methods

1.3.   Research Approaches

2.1.   Covid-19 Vaccines Market Highlights

2.2.   Covid-19 Vaccines Market Projection

2.3.   Covid-19 Vaccines Market Regional Highlights

3.1.   Introduction

3.2.   Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3.   Porter's Five Forces Analysis

3.4.   IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Type

3.4.2. IGR-Growth Matrix Analysis by Region

3.5.   Value Chain Analysis of Covid-19 Vaccines Market

5.1.   mRNA-based Vaccine

5.2.   Adenovirus Vaccine

5.3.   Recombinant Adenovirus Vaccine

5.4.   Non-replicating Viral Vector

5.5.   Inactivated Vaccine

6.1.   North America

6.1.1. North America Covid-19 Vaccines Market by Type

6.1.2. North America Covid-19 Vaccines Market by Country

6.2.   Europe

6.2.1. Europe Covid-19 Vaccines Market by Type

6.2.2. Europe Covid-19 Vaccines Market by Country

6.3.   Asia-Pacific

6.3.1. Asia-Pacific Covid-19 Vaccines Market by Type

6.3.2. Asia-Pacific Covid-19 Vaccines Market by Country

6.4.   RoW

6.4.1. RoW Covid-19 Vaccines Market by Type

6.4.2. RoW Covid-19 Vaccines Market by Sub-region

7.1.   Competitive Landscape in the Global Covid-19 Vaccines Market

7.2.   Companies Profiles

7.2.1. AstraZeneca plc

7.2.2. GlaxoSmithKline plc

7.2.3. Pfizer Inc.

7.2.4. Bharat Biotech International Limited

7.2.5. Johnson & Johnson

7.2.6. Serum Institute of India

7.2.7. Novavax, iNC.

7.2.8. Sinovac Biotech

7.2.9. CureVac N.V.

7.2.10.   Moderna Inc.